Drawing for VYAIRE MEDICAL

USPTO serial 87121996

VYAIRE MEDICAL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SINGLETON, RUDY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VYAIRE MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Barbara Grahn

Barbara Grahn FOX ROTHSCHILD LLP222 SOUTH NINTH STREETSUITE 2000MINNEAPOLIS, MN 55402

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware for medical purposes; Computer software for medical purposes, namely, for collecting, analyzing and reporting medical data and patient information to aid clinicians in treatment, therapy, and improving patient care, for cardio-pulmonary exercise testing, and for sleep diagnostics; Computer software for medical diagnosis, management and organization of patient data, workflow management, communication between patients and healthcare providers, stored data processing and data management, all of the foregoing for medical purposes; Computer software to monitor and process arterial oxygen saturation and adjust the level of inspired oxygen; Cardio-pulmonary resuscitation mannequinsACTIVE—
010Medical apparatus and instruments for use in respiratory diagnostics and therapy, and component parts therefor; Medical apparatus and instruments for use in patient monitoring and anesthesia delivery and component parts therefor; Medical consumables, being cannulas, patient circuits, catheters, suction catheters, filters, for use in respiratory diagnostics and therapy, patient monitoring, and anesthesia delivery; Medical apparatus, namely, respiratory equipment; Medical products, namely, respiratory sensors, flow sensors, pressure sensors, temperature sensors; Medical ventilators and component parts therefor; Control system composed of computer-controlled, electromechanical components for use in operating medical ventilators comprising primarily control panels, monitors, valves, transducers, vital signs sensors, gas composition and flow sensors and controls, temperature sensors and controls, pressure sensors and controls; Medical ventilators for pediatric and neonatal patients; Medical respirators and component parts therefor; Nebulizers for respiratory therapy; Medical and veterinary apparatus, namely, apparatus for medical ventilation, artificial respiration, and resuscitation; Medical apparatus and instruments for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events; Leads, cables, connectors and conductors for connecting a patient to monitors, alarms, analyzer, displays, acquisition modules, recorders, transmitters and memories of and for psychological data; Medical apparatus for intravenous administration of fluids, namely, fluid warmers; Spirometers; Plethysmographs; Humidifiers for medical use and component parts and accessories therefor, namely, heating units, chambers, breathing circuits, sensors, heat and moisture filters; Cardiopulmonary monitoring equipment; Surgical drapes; Electrocardiographic electrodes; Tracheal catheters; Esophageal catheters; Airway adaptors for respiratory ventilation systems; Breathing apparatus for gas inhalation and nebulization, cardiopulmonary therapy, resuscitation and anesthesia, and chemotherapy; Anesthesia breathing circuit; Medical diagnostic devices for cardiopulmonary exercise testing, pulmonary function analysis, respiratory mechanics assessment, and/or nutritional assessment; Electro-medical devices used to administer and monitor anesthetics, anesthetic gases and oxygen, and structural parts for such apparatus; Devices for aiding in the administration of gaseous anesthetic agents and component parts therefor; Medical apparatus and instruments for measuring and monitoring arterial oxygen saturation and automatically adjusting delivered oxygen; Gas sensors for detecting and measuring the concentration of nitric oxide, nitrogen dioxide, carbon monoxide, carbon dioxide, hydrogen and oxygen for medical purposes; Apparatus for aiding, controlling and monitoring the respiration of infants; Respiratory masks for medical purposes; Breathing circuits; Portable respirators and air compressors; Automatic resuscitators; Emergency hand resuscitators; Manual resuscitators; Blood pressure cuffs; Pressure infusors; Laryngoscopes; Laryngoscope handles and blades; Anesthesia systems comprised of flexible hoses, breathing bags and a Y-elbow; Tracheotomy fittings, endotracheal adapters, intubation adapters, suction catheters, and component parts therefor; Devices for precise mixing of compressed air and oxygen, and component parts therefor; Deicers for warming and humidifying medical gases; Medical oxygen tubing; Tongue positioning mouthpiece; Mouth filter for exhaled breath for medical use; Medical apparatus, namely, continuous positive airway pressure (CPAP) devices; Medical diagnostic instrument system, namely, computer-based data receivers, data processors, displays and recorders, for evaluation of patient sleep respiratory disorders and other physical characteristics during sleep; Arterial blood gas sampling kits comprising needles, sheaths and clips; Respiratory gas blendersACTIVE—
042Providing online non-downloadable software for collecting, analyzing and reporting medical data and patient information to aid clinicians in treatment, therapy, and improving patient care; Providing online non-downloadable software for cardio-pulmonary exercise testing; Providing online non-downloadable software for sleep diagnostics; Providing online non-downloadable software for medical diagnosis, management and organization of patient data, workflow management, communication between patients and healthcare providers, stored data processing and data management; Providing online non-downloadable software to monitor and process arterial oxygen saturation and adjust the level of inspired oxygen; all of the foregoing for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 26, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 26, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 24, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 23, 2020EX5GSOU EXTENSION 5 GRANTED—
Mar 17, 2020EXT5SOU EXTENSION 5 FILED—
Mar 17, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 24, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 23, 2019EX4GSOU EXTENSION 4 GRANTED—
Sep 17, 2019EXT4SOU EXTENSION 4 FILED—
Sep 17, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 22, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 21, 2019EX3GSOU EXTENSION 3 GRANTED—
Mar 19, 2019EXT3SOU EXTENSION 3 FILED—
Mar 19, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 27, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 26, 2018EX2GSOU EXTENSION 2 GRANTED—
Sep 26, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 18, 2018EXT2SOU EXTENSION 2 FILED—
Sep 18, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 19, 2018EX1GSOU EXTENSION 1 GRANTED—
Mar 19, 2018EXT1SOU EXTENSION 1 FILED—
Mar 19, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 19, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 25, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 25, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 5, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 21, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 15, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 15, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jun 15, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 15, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 15, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 13, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 13, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 8, 2017ALIEASSIGNED TO LIE—
May 14, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 14, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 10, 2016DOCKASSIGNED TO EXAMINER—
Aug 3, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 3, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance